Group 1 - The aging population in China is leading to an increase in presbyopia, with nearly 100% prevalence in individuals over 52 years old, creating a significant public health issue affecting millions [1][3] - Current presbyopia correction methods include optical correction (glasses), surgical correction, and drug treatment, each with its own advantages and disadvantages [1][2] - Surgical correction methods, such as artificial lens implantation and laser correction, are becoming increasingly important as technology advances, with a low current penetration rate in China indicating potential for rapid growth [1][2][3] Group 2 - The cost of presbyopia correction surgery varies, with lens replacement surgery typically costing between 300,000 to 1,000,000 RMB for both eyes, while laser correction ranges from 20,000 to 60,000 RMB [2] - The market for presbyopia correction is expected to grow significantly, driven by increasing awareness and demand among the working population aged 45 to 60 [4][6] - The private sector currently holds about 60% of the presbyopia correction market, benefiting from flexible service mechanisms and rapid technological advancements, while public hospitals focus on basic medical needs [14][15] Group 3 - New treatment methods, such as presbyopia eye drops, are in clinical trials, with the potential to improve vision by pharmacologically constricting the pupil, although they require continuous use and may cause side effects [4][10] - Companies like Aier Eye Hospital and Devision are actively involved in the presbyopia correction market, with Aier focusing on multi-focal lenses to address both presbyopia and myopia [3][10] - The integration of multi-disciplinary teams in eye care is being promoted to address the complexities of treating patients with multiple eye conditions, enhancing the overall patient experience [15]